Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CEL SCI CORP Regulatory Filings 2012

Dec 26, 2012

34401_rns_2012-12-26_ba2d72b3-ced9-4fc1-adca-d7b428de8f9a.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 cvm_8k.htm CURRENT REPORT cvm_8k.htm Licensed to: Issuer Direct Corp. Document Created using EDGARizerAgent 5.4.1.0 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): December 18, 2012

CEL-SCI CORPORATION

(Exact name of Registrant as specified in its charter)

Colorado 001-11889 84-0916344
(State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.)

8229 Boone Boulevard, Suite 802 Vienna, Virginia 22182

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (703) 506-9460


(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 18, 2012 the Company’s directors approved the issuance of options to the Company’s officers and directors. All options are exercisable at a price of $0.28 per share. Other information concerning the options follows:

Name of Officer/Director Shares Issuable Upon Exercise of Options Type of Options Vesting Schedule (1)
Maximilian de Clara 1,000,000 Non-qualified stock option Equally and annually over 5 years
Geert R. Kersten 2,300,000 Non-qualified stock option Equally and annually over 5 years
Geert R. Kersten 2,700,000 Incentive stock option As shown below
Eyal Talor, Ph.D. 1,500,000 Incentive stock option As shown below
Patricia B. Prichep 1,500,000 Incentive stock option As shown below
Dr. C. Richard Kinsolving 500,000 Non-qualified stock option Equally and annually over 5 years
Dr. Peter R. Young 500,000 Non-qualified stock option Equally and annually over 5 years
Alexander G. Esterhazy 500,000 Non-qualified stock option Equally and annually over 5 years

2

Vesting Schedule:

Options Date Options are
Name Exercisable First Exercisable
Geert R. Kersten 110,770 12-18-13
110,770 12-18-14
354,090 12-18-15
354,085 12-18-16
354,085 12-18-17
354,085 12-18-18
354,085 12-18-19
354,085 12-18-20
354,085 12-18-21
Eyal Talor, Ph.D. 233,900 12-18-13
233,900 12-18-14
344,067 12-18-15
344,067 12-18-16
344,066 12-18-17
Patricia B. Prichep 233,900 12-18-13
233,900 12-18-14
344,067 12-18-15
344,067 12-18-16
344,066 12-18-17

(1) Any options which are not then exercisable will automatically terminate 90 days after the date the option holder voluntarily resigns as an officer, director or employee or in the event the option holder is terminated for cause. For purposes of these options, cause is defined as (i) the failure by the option holder to substantially perform his duties and obligations owed to the Corporation (other than any failure resulting from incapacity due to physical or mental illness); (ii) engaging in misconduct or a breach of fiduciary duty which is, or potentially is, materially injurious to the Corporation; (iii) the commission of a crime which is, or potentially is, materially injurious to the Corporation.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has only caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Patricia B. Prichep
Patricia B. Prichep
Senior Vice President of Operations

4